ELI LILLY AND COMPANY v. SUN PHARMACEUTICAL INDUSTRIES LTD
1:06-cv-01721
Overview
Parties
Defendant
SUN PHARMACEUTICAL INDUSTRIES LTD Operating Company
Represented By
5 Attorneys ListedRILEY BENNETT & EGLOFF LLP
141 East Washington Street, Suite 400
COHEN PONTANI LIEBERMAN & PAVANE
COHEN PONTANI LIEBERMAN & PAVANE, 551 Fifth Avenue
COHEN PONTANI LIEBERMAN & PAVANE
COHEN PONTANI LIEBERMAN & PAVANE, 551 Fifth Avenue
COHEN PONTANI LIEBERMAN & PAVANE
COHEN PONTANI LIEBERMAN & PAVANE, 551 Fifth Avenue
COHEN PONTANI LIEBERMAN & PAVANE
COHEN PONTANI LIEBERMAN & PAVANE, 551 Fifth Avenue
Consol Plaintiff
ELI LILLY AND COMPANY Operating Company
Represented By
5 Attorneys ListedFINNEGAN HENDERSON FARABOW GARRETT & DUNNER LLP
3300 Hillview Avenue, Palo Alto, CA 94304
FINNEGAN HENDERSON FARABOW GARRETT & DUNNER LLP
11955 Freedom Drive, Reston, VA 20190
BARNES & THORNBURG LLP
11 South Meridian Street, Indianapolis, IN 46204
FINNEGAN HENDERSON FARABOW GARRETT & DUNNER LLP
901 New York Avenue NW, Washington, DC 20001
FINNEGAN HENDERSON FARABOW GARRETT & DUNNER LLP
901 New York Avenue N.W., Washington, DC 20001
Court & Judges
Court
District Court, S.D. Indiana (insd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 6 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5464826
Method of treating tumors in mammals with 2',2'-difluoronucleosides
|
Filed: 1994-07-26
Issued: 1995-11-07
|
Expired (Term Ended)
Expires: 2014-07-26
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
26
Dispositive
22
Granted
5
Denied
0
Pending / Review
14
Motions by Category
Key Dispositive Motions & Rulings